Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Figure out How to Really focus on Your Dental Inserts for Durable Outcomes - 2The Solution to Individual budget: Dominating Cash The board
- 3JFK's granddaughter reveals terminal cancer diagnosis, criticizes cousin RFK Jr.
- 4Figure out How to Pick a Crematorium: Key Contemplations.
- 5‘Dying of thirst’: Inside Gaza’s al-Mawasi water crisis
- Kansas school officials report high student illness, dismiss early
- German gas price bill signed into law, but consumers not impressed
- Figure out How to Remain Informed about the Most recent Open Record Extra Offers
- Brazil approves law strengthening protective measures for female victims of gender-based violence
- 'Senseless violence' erupts at Christmas tree lighting; 4 injured
- Watch Atlas V rocket launch its heaviest-ever payload early on April 4
- 4 astronauts are en route home from ISS after medical issue forces early exit
- The Advancement and Effect of Dental Embed Innovation on Oral Wellbeing
- JFK's granddaughter Tatiana Schlossberg reveals terminal cancer diagnosis
